Global AI for Drug Discovery Market Opportunities & Forecast (2018-2025)-GMI Research

Global AI for Drug Discovery Market by Drug Type (Small Molecule and Large Molecules), By Technology (Deep Learning and machine learning), By Therapeutic Type (Metabolic Disease, Cardiovascular Disease, Oncology, Neurodegenerative Diseases and Others) End-Users (Pharmaceutical Companies, Biopharmaceutical Companies, Academic and Research Institutes and Others) and by Geography – Opportunities & Forecast, 2018-2025

Drug discovery is the initial step in the process of a novel drug candidate’s identification and its therapeutic target. Drug discovery or new drug target are being evaluated based on efficacy, potency, bioavailability, and toxicity. Artificial intelligence is widely used in the healthcare industry and especially used for drug discovery. Artificial intelligence technology has the capability to recognize drug targets, and play an important role in drug design, discovery, identification and screening of molecules instantly and effectively. The global AI for the drug discovery market is highly fragmented and have a lower level of competition as few companies matched the required level of expertise. For instance, there are more than 100 AI companies in the world today but only a few of them can enter the AI in the drug discovery sector due to the lack of expertise

Request Sample Pages : https://tinyurl.com/y9lwjq79

The AI for Drug Discovery market is rapidly growing, due to the rising number of cross-industry partnerships and collaborations, a significant increase in venture capital investments. Furthermore, the growth in importance of drug discovery and rise in funding of the R&D activities for the use of AI technology in the field of drug discovery is expected to fuel the market growth. Moreover, untapped market opportunities in developing regions such as India and China will support the growth of artificial intelligence in drug discovery in the coming years. However, reluctance among medical practitioners to adopt AI-based technologies, ambiguous regulatory guidelines for medical software and lack of interoperability between AI solutions offered by different vendors are few factors which may impede the growth of AI for drug discovery market during the forecast period.

Various notable players operating in the market, include Atomwise, Insilco Medicine, Inc., BIOAGE, Exscientia, twoXAR, Incorporated, Numerate, Inc., NuMedii, Inc., Envisagenics, Globavir, Inc. Cloud Pharmaceuticals, Inc, BenevolentAI among others. Major players are looking toward AI to speed up drug discovery, cut R&D costs, decrease failure rates in drug trials, and eventually create better medicines. For instance, Pfizer entered into research collaboration with IBM Watson to design a system that uses machine learning, to power its search for immuno-oncology drugs.

The global AI for drug discovery market has been segmented on the basis of drug type, technology type, therapeutic type, end-use, and key geographies. Based on drug type, the market comprises of the drug type small molecule and large molecules. The research report “global AI for Drug Discovery market” provides in-depth analysis of global AI for drug discovery market based on drug type, technology, therapeutic, end-user and major geographies for the forecast period from 2018 to 2025. The report also highlights the major market drivers propelling the growth as well as challenges faced by market participants. The research report provides market size and forecast for the global AI for the drug discovery market. In addition, the report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

Key questions answered in this research report:
1- At what pace is AI for the drug discovery market growing? What will be the growth trend in the future?
2- What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the future?
3- What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in the AI for the drug discovery market?
4- What are the various application areas and how they are poised to grow?

Market Segmentation

By Drug Type
• Small Molecule
• Large Molecules

By Technology
• Deep Learning
• Machine Learning

By Therapeutic Type
• Metabolic Disease
• Cardiovascular Disease
• Oncology
• Neurodegenerative Diseases
• Others

By End-Users
• Pharmaceutical Companies
• Biopharmaceutical Companies
• Academic and Research Institutes
• Others

By Geography
• North America
As a part of customization
o By Drug Type
o By Technology Type
o By Therapeutic
o By End users
o US
o Canada
o Mexico

• Europe
As a part of customization
o By Drug Type
o By Technology Type
o By Therapeutic
o By End users
o UK
o Germany
o Spain
o Rest of Europe

• Asia-Pacific
As a part of customization
o By Drug Type
o By Technology Type
o By Therapeutic
o By End users
o China
o Australia
o India
o Rest of APAC

• ROW
As a part of customization
o By Drug Type
o By Technology Type
o By Therapeutic
o By End users
o Brazil
o South Africa
o GCC countries
o Rest of world (remaining countries of the LAMEA region)

Leading market players
• Atomwise
• Insilico Medicine, Inc.
• BIOAGE
• Numerate, Inc.
• NuMedii, Inc.
• Envisagenics
• Globavir, Inc.
• Cloud Pharmaceuticals, Inc,
• BenevolentAI

*Other prominent players in the market which can be profiled as a part of customization:
• Exscientia
• twoXAR, Incorporated

For Sample Pages & Detailed Report Description Click @ https://www.gmiresearch.com/report/global-artificial-intelligence-ai-drug-discovery-market-opportunities-forecast-technology-therapeutic-share-insights.html

Table of Contents (TOC)

1. Executive Summary

2. Introduction
2.1. Study Objectives
2.2. Market Definition
2.2.1. Market Covered
2.2.2. Geographical Coverage
2.2.3. Study Years & Currency
2.3. Market Stakeholders
2.4. Key Questions this Study will Answer
2.5. GMI Research’s Approach & Methodology

3. Global AI for Drug Discovery Devices Market – Overview
3.1. Introduction `
3.2. Market Segmentation
3.3. Pipeline Analysis
3.4. Regulatory Scenario
3.5. Drivers
3.6. Restraints
3.7. Trends

4. Global AI for Drug Discovery Devices Market Revenue Forecast till 2025

5. Global AI for Drug Discovery Devices Market by Drug Type Revenue Forecast till 2025
5.1. Small Molecule
5.2. Large Molecules

6. Global AI for Drug Discovery Devices Market by Technology Revenue Forecast till 2025
6.1. Deep Learning
6.2. Machine Learning

7. Global AI for Drug Discovery Devices Market by Therapeutic Revenue Forecast till 2025
7.1. Metabolic Disease
7.2. Cardiovascular Disease
7.3. Oncology
7.4. Neurodegenerative Diseases
7.5. Others

8. Global AI for Drug Discovery Devices Market by End User Revenue Forecast till 2025
8.1. Pharmaceutical Companies
8.2. Biopharmaceutical Companies
8.3. Academic and Research Institutes
8.4. Others

9. Global AI for Drug Discovery Devices Market by Geography Revenue Forecast till 2025
9.1. North America AI for Drug Discovery Devices Market Revenue Forecast till 2025
9.1.1. North America AI for Drug Discovery Devices Market by Drug Type

(Option 1: 25% customization)
9.1.1.1. Small Molecule
9.1.1.2. Large Molecules
9.1.2. North America AI for Drug Discovery Devices Market by Technology
9.1.2.1. Deep Learning
9.1.2.2. Machine Learning
9.1.3. North America AI for Drug Discovery Devices Market by Therapeutic
9.1.3.1. Metabolic Disease
9.1.3.2. Cardiovascular Disease
9.1.3.3. Oncology
9.1.3.4. Neurodegenerative Diseases
9.1.3.5. Others
9.1.4. North America AI for Drug Discovery Devices Market by End User
9.1.4.1. Pharmaceutical Companies
9.1.4.2. Biopharmaceutical Companies
9.1.4.3. Academic and Research Institutes
9.1.4.4. Others
9.2. Europe AI for Drug Discovery Devices Market Revenue Forecast till 2025
9.2.1. Europe AI for Drug Discovery Devices Market by Drug Type (Option 2: 25% customization)
9.2.1.1. Small Molecule
9.2.1.2. Large Molecules
9.2.2. Europe AI for Drug Discovery Devices Market by Technology
9.2.2.1. Deep Learning
9.2.2.2. Machine Learning
9.2.3. Europe AI for Drug Discovery Devices Market by Therapeutic
9.2.3.1. Metabolic Disease
9.2.3.2. Cardiovascular Disease
9.2.3.3. Oncology
9.2.3.4. Neurodegenerative Diseases
9.2.3.5. Others
9.2.4. Europe AI for Drug Discovery Devices Market by End User
9.2.4.1. Pharmaceutical Companies
9.2.4.2. Biopharmaceutical Companies
9.2.4.3. Academic and Research Institutes
9.2.4.4. Others
9.3. Asia-Pacific AI for Drug Discovery Devices Market Revenue Forecast till 2025
9.3.1. Asia-Pacific AI for Drug Discovery Devices Market by Drug Type

(Option 3: 25% customization)
9.3.1.1. Small Molecule
9.3.1.2. Large Molecules
9.3.2. Asia-Pacific AI for Drug Discovery Devices Market by Technology
9.3.2.1. Deep Learning
9.3.2.2. Machine Learning
9.3.3. Asia-Pacific AI for Drug Discovery Devices Market by Therapeutic
9.3.3.1. Metabolic Disease
9.3.3.2. Cardiovascular Disease
9.3.3.3. Oncology
9.3.3.4. Neurodegenerative Diseases
9.3.3.5. Others
9.3.4. Asia-Pacific AI for Drug Discovery Devices Market by End User
9.3.4.1. Pharmaceutical Companies
9.3.4.2. Biopharmaceutical Companies
9.3.4.3. Academic and Research Institutes
9.3.4.4. Others
9.4. Rest of the World AI for Drug Discovery Devices Market Revenue Forecast till 2025
9.4.1. Rest of the World AI for Drug Discovery Devices Market by Drug Type

(Option 4: 25% customization)
9.4.1.1. Small Molecule
9.4.1.2. Large Molecules
9.4.2. Rest of the World AI for Drug Discovery Devices Market by Technology
9.4.2.1. Deep Learning
9.4.2.2. Machine Learning
9.4.3. Rest of the World AI for Drug Discovery Devices Market by Therapeutic
9.4.3.1. Metabolic Disease
9.4.3.2. Cardiovascular Disease
9.4.3.3. Oncology
9.4.3.4. Neurodegenerative Diseases
9.4.3.5. Others
9.4.4. North America AI for Drug Discovery Devices Market by End User
9.4.4.1. Pharmaceutical Companies
9.4.4.2. Biopharmaceutical Companies
9.4.4.3. Academic and Research Institutes
9.4.4.4. Others

10. Competitive Landscape
10.1. Industry Attractiveness
10.2. Porter 5 Analysis
10.3. Major players and their key strategies
10.4. Company Share Analysis

11. Company Profiles (Option 5: 25% Customization – Profiles of 5 Additional Companies of

your Choice)
11.1. Atomwise
11.1.1. Company Overview
11.1.2. Financials
11.1.3. Recent Developments
11.2. Insilico Medicine, Inc.
11.2.1. Company Overview
11.2.2. Financials
11.2.3. Recent Developments
11.3. BIOAGE
11.3.1. Company Overview
11.3.2. Financials
11.3.3. Recent Developments
11.4. Numerate, Inc.
11.4.1. Company Overview
11.4.2. Financials
11.4.3. Recent Developments
11.5. NuMedii, Inc.
11.5.1. Company Overview
11.5.2. Financials
11.5.3. Recent Developments
11.6. Envisagenics
11.6.1. Company Overview
11.6.2. Financials
11.6.3. Recent Developments
11.7. Cloud Pharmaceuticals, Inc.
11.7.1. Company Overview
11.7.2. Financials
11.7.3. Recent Developments
11.8. BenevolentAI
11.8.1. Company Overview
11.8.2. Financials
11.8.3. Recent Developments
11.9. Exscientia
11.9.1. Company Overview
11.9.2. Financials
11.9.3. Recent Developments
11.10. twoXAR, Incorporated
11.10.1. Company Overview
11.10.2. Financials
11.10.3. Recent Developments

12. About GMI Research

Buy Report @ https://tinyurl.com/y9lwjq79

Our Customized Research (Market Intelligence and Competitive Intelligence) Offerings

Our clients rely on us for the range of our services to give them the intelligence they need to act decisively. GMI Research offers in-depth market and competitive intelligence solutions by leveraging its industry knowledge and experience to provide accurate insights with a complete picture of the market and competition. To know more about our product offering click on the below link:

https://www.gmiresearch.com/productservices/marketcompetitiveintelligence.html

Our Company Profile Solution

Company Profiles provide an insight on competitors, customers, and potential suppliers. We at GMI Research understands that the standard or on shelf company profiles provides little help when it comes to business decision making as it doesn’t cover the information required by the clients.

We have developed a range of company profiles solution to meet our client’s specific business requirements irrespective of their role and the industry they operate in. Our company profiles solutions fit into our client’s business requirements because it provides our client’s with a broader choice of profiles:

https://www.gmiresearch.com/productservices/companyprofiles.html

Contact – Sarah Nash

GMI Research is a market research and consulting firm which provides research-based solutions to business executives and investment professionals so that they can make right business & investment decisions faster based on real facts. We help business leaders through independent fact-based insight, ensuring their business achieve success by beating the competition.

GMI Research leverages its industry expertise and experience to identify the industry trends, big opportunities and potential growth areas across industries. Our Syndicated reports provide actionable insights and covers industry trends, market drivers & restraints, macroeconomics factors, market estimates & forecasts, competitive landscape etc. which helps our clients to strengthen its market position by deploying specific strategies and actions that will lead to higher growth.

Level 1, The Chase Carmanhall Road,
Sandyford Industrial Estate,
Dublin D18 Y3X2, Ireland
U.S Office +1 860 881 2270
Europe Office +353 1 442 8820
Email: sales@gmiresearch.com

This release was published on openPR.